Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1

Epileptic encephalopathies are a devastating group of epilepsies with a poor prognosis, for which the majority have unknown etiology.

Contribution: performed mutation segregation analysis

Read the rest of this article in Nature Genetics

Advertisements